Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 275

1.

Incidence, outcomes, and risk factors of pleural effusion in patients receiving dasatinib therapy for Philadelphia chromosome-positive leukemia.

Hughes TP, Laneuville P, Rousselot P, Snyder DS, Rea D, Shah NP, Paar D, Abruzzese E, Hochhaus A, Lipton JH, Cortes JE.

Haematologica. 2018 Aug 9. pii: haematol.2018.188987. doi: 10.3324/haematol.2018.188987. [Epub ahead of print]

2.

Human case of Fasciola gigantica-like infection, review of human fascioliasis reports in Nepal, and epidemiological analysis within the South Central Asia.

Sah R, Khadka S, Lakhey PJ, Pradhan S, Shah NP, Singh YP, Mas-Coma S.

Acta Parasitol. 2018 Sep 25;63(3):435-443. doi: 10.1515/ap-2018-0053.

PMID:
29975653
3.

Effects of Lactobacillus rhamnosus GG and Escherichia coli Nissle 1917 Cell-Free Supernatants on Modulation of Mucin and Cytokine Secretion on Human Intestinal Epithelial HT29-MTX Cells.

Wan ML, Chen Z, Shah NP, El-Nezami H.

J Food Sci. 2018 Jul;83(7):1999-2007. doi: 10.1111/1750-3841.14168. Epub 2018 Jun 4.

PMID:
29863797
4.

Quizartinib, an FLT3 inhibitor, as monotherapy in patients with relapsed or refractory acute myeloid leukaemia: an open-label, multicentre, single-arm, phase 2 trial.

Cortes J, Perl AE, Döhner H, Kantarjian H, Martinelli G, Kovacsovics T, Rousselot P, Steffen B, Dombret H, Estey E, Strickland S, Altman JK, Baldus CD, Burnett A, Krämer A, Russell N, Shah NP, Smith CC, Wang ES, Ifrah N, Gammon G, Trone D, Lazzaretto D, Levis M.

Lancet Oncol. 2018 Jul;19(7):889-903. doi: 10.1016/S1470-2045(18)30240-7. Epub 2018 May 31.

PMID:
29859851
5.

Design and rationale for the life after stopping tyrosine kinase inhibitors (LAST) study, a prospective, single-group longitudinal study in patients with chronic myeloid leukemia.

Atallah E, Schiffer CA, Weinfurt KP, Zhang MJ, Radich JP, Oehler VG, Pinilla-Ibarz J, Deininger MWN, Lin L, Larson RA, Mauro MJ, Moore JO, Ritchie EK, Shah NP, Silver RT, Wadleigh M, Cortes J, Thompson J, Guhl J, Horowitz MM, Flynn KE.

BMC Cancer. 2018 Apr 2;18(1):359. doi: 10.1186/s12885-018-4273-1.

6.
7.

Physicochemical and textural properties of mozzarella cheese made with konjac glucomannan as a fat replacer.

Dai S, Jiang F, Corke H, Shah NP.

Food Res Int. 2018 May;107:691-699. doi: 10.1016/j.foodres.2018.02.069. Epub 2018 Feb 28.

PMID:
29580536
8.

Ponatinib efficacy and safety in Philadelphia chromosome-positive leukemia: final 5-year results of the phase 2 PACE trial.

Cortes JE, Kim DW, Pinilla-Ibarz J, le Coutre PD, Paquette R, Chuah C, Nicolini FE, Apperley JF, Khoury HJ, Talpaz M, DeAngelo DJ, Abruzzese E, Rea D, Baccarani M, Müller MC, Gambacorti-Passerini C, Lustgarten S, Rivera VM, Haluska FG, Guilhot F, Deininger MW, Hochhaus A, Hughes TP, Shah NP, Kantarjian HM.

Blood. 2018 Jul 26;132(4):393-404. doi: 10.1182/blood-2016-09-739086. Epub 2018 Mar 22.

9.

Bifurcation of the inferior dental nerve canal: an anatomical study.

Shah NP, Murtadha L, Brown J.

Br J Oral Maxillofac Surg. 2018 May;56(4):267-271. doi: 10.1016/j.bjoms.2018.01.016. Epub 2018 Mar 7.

PMID:
29525294
10.

Rational Design, Synthesis and Biological Evaluation of Pyrimidine-4,6-diamine derivatives as Type-II inhibitors of FLT3 Selective Against c-KIT.

Bharate JB, McConnell N, Naresh G, Zhang L, Lakkaniga NR, Ding L, Shah NP, Frett B, Li HY.

Sci Rep. 2018 Feb 27;8(1):3722. doi: 10.1038/s41598-018-21839-3.

11.

Cardiac Rehabilitation: Current Review of the Literature and Its Role in Patients with Heart Failure.

Shah NP, AbuHaniyeh A, Ahmed H.

Curr Treat Options Cardiovasc Med. 2018 Feb 24;20(2):12. doi: 10.1007/s11936-018-0611-5. Review.

PMID:
29478150
12.

Front-Line Treatment Options for Chronic-Phase Chronic Myeloid Leukemia.

Shah NP.

J Clin Oncol. 2018 Jan 20;36(3):220-224. doi: 10.1200/JCO.2017.75.4663. Epub 2017 Dec 5.

PMID:
29206554
13.

Restoration of GABA production machinery in Lactobacillus brevis by accessible carbohydrates, anaerobiosis and early acidification.

Wu Q, Shah NP.

Food Microbiol. 2018 Feb;69:151-158. doi: 10.1016/j.fm.2017.08.006. Epub 2017 Aug 16.

PMID:
28941896
14.

Human fascioliasis by Fasciola hepatica: the first case report in Nepal.

Sah R, Khadka S, Khadka M, Gurubacharya D, Sherchand JB, Parajuli K, Shah NP, Kattel HP, Pokharel BM, Rijal B.

BMC Res Notes. 2017 Sep 5;10(1):439. doi: 10.1186/s13104-017-2761-z.

15.

Effect of Type of Protein-Based Microcapsules and Storage at Various Ambient Temperatures on the Survival and Heat Tolerance of Spray Dried Lactobacillus acidophilus.

Dianawati D, Lim SF, Ooi YBH, Shah NP.

J Food Sci. 2017 Sep;82(9):2134-2141. doi: 10.1111/1750-3841.13820. Epub 2017 Aug 26.

PMID:
28843042
16.

Health-promoting benefits of low-fat akawi cheese made by exopolysaccharide-producing probiotic Lactobacillus plantarum isolated from camel milk.

Al-Dhaheri AS, Al-Hemeiri R, Kizhakkayil J, Al-Nabulsi A, Abushelaibi A, Shah NP, Ayyash M.

J Dairy Sci. 2017 Oct;100(10):7771-7779. doi: 10.3168/jds.2017-12761. Epub 2017 Jul 26.

PMID:
28755944
17.

Imipramine blue sensitively and selectively targets FLT3-ITD positive acute myeloid leukemia cells.

Metts J, Bradley HL, Wang Z, Shah NP, Kapur R, Arbiser JL, Bunting KD.

Sci Rep. 2017 Jun 30;7(1):4447. doi: 10.1038/s41598-017-04796-1.

18.

Evaluation of cardiovascular ischemic event rates in dasatinib-treated patients using standardized incidence ratios.

Saglio G, le Coutre P, Cortes J, Mayer J, Rowlings P, Mahon FX, Kroog G, Gooden K, Subar M, Shah NP.

Ann Hematol. 2017 Aug;96(8):1303-1313. doi: 10.1007/s00277-017-3012-z. Epub 2017 May 22.

19.

Beyond ONJ - A review of the potential uses of bisphosphonates in dentistry.

Shah NP, Nayee S, Pazianas M, Sproat C.

Br Dent J. 2017 May 12;222(9):727-730. doi: 10.1038/sj.bdj.2017.412. Review.

PMID:
28496240
20.

Heterogeneous resistance to quizartinib in acute myeloid leukemia revealed by single-cell analysis.

Smith CC, Paguirigan A, Jeschke GR, Lin KC, Massi E, Tarver T, Chin CS, Asthana S, Olshen A, Travers KJ, Wang S, Levis MJ, Perl AE, Radich JP, Shah NP.

Blood. 2017 Jul 6;130(1):48-58. doi: 10.1182/blood-2016-04-711820. Epub 2017 May 10.

21.

Common Distribution of gad Operon in Lactobacillus brevis and its GadA Contributes to Efficient GABA Synthesis toward Cytosolic Near-Neutral pH.

Wu Q, Tun HM, Law YS, Khafipour E, Shah NP.

Front Microbiol. 2017 Feb 14;8:206. doi: 10.3389/fmicb.2017.00206. eCollection 2017.

22.

Mutual growth-promoting effect between Bifidobacterium bifidum WBBI03 and Listeria monocytogenes CMCC 54001.

Yang D, Wu X, Yu X, He L, Shah NP, Xu F.

J Dairy Sci. 2017 May;100(5):3448-3462. doi: 10.3168/jds.2016-11804. Epub 2017 Mar 2.

PMID:
28259400
23.

Physiological Changes of Surface Membrane in Lactobacillus with Prebiotics.

Pan M, Kumaree KK, Shah NP.

J Food Sci. 2017 Mar;82(3):744-750. doi: 10.1111/1750-3841.13608. Epub 2017 Feb 15.

PMID:
28199749
24.
25.

Beneficial effects of probiotic cholesterol-lowering strain of Enterococcus faecium WEFA23 from infants on diet-induced metabolic syndrome in rats.

Zhang F, Qiu L, Xu X, Liu Z, Zhan H, Tao X, Shah NP, Wei H.

J Dairy Sci. 2017 Mar;100(3):1618-1628. doi: 10.3168/jds.2016-11870. Epub 2016 Dec 29.

PMID:
28041735
26.

NCCN Guidelines Insights: Chronic Myeloid Leukemia, Version 1.2017.

Pallera A, Altman JK, Berman E, Abboud CN, Bhatnagar B, Curtin P, DeAngelo DJ, Gotlib J, Hagelstrom RT, Hobbs G, Jagasia M, Kantarjian HM, Kropf P, Metheny L, Moore JO, Ontiveros E, Purev E, Quiery A, Reddy VV, Rose MG, Shah NP, Smith BD, Snyder DS, Sweet KL, Tibes R, Yang DT, Gregory K, Sundar H, Deininger M, Radich JP.

J Natl Compr Canc Netw. 2016 Dec;14(12):1505-1512.

PMID:
27956535
27.

Identification and characterization of activating ABL1 1b kinase mutations: impact on sensitivity to ATP-competitive and allosteric ABL1 inhibitors.

Lee BJ, Shah NP.

Leukemia. 2017 May;31(5):1096-1107. doi: 10.1038/leu.2016.353. Epub 2016 Nov 28.

PMID:
27890928
28.

The potential of species-specific tagatose-6-phosphate (T6P) pathway in Lactobacillus casei group for galactose reduction in fermented dairy foods.

Wu Q, Shah NP.

Food Microbiol. 2017 Apr;62:178-187. doi: 10.1016/j.fm.2016.10.027. Epub 2016 Oct 13.

PMID:
27889146
30.

Snowflakes in August: Leptospirosis Hemorrhagic Pneumonitis.

Sathiyakumar V, Shah NP, Niranjan-Azadi A, Tao J, Tsao A, Martin IW, Brotman DJ, Antar AA.

Am J Med. 2017 Jan;130(1):e9-e11. doi: 10.1016/j.amjmed.2016.07.015. Epub 2016 Aug 16. No abstract available.

PMID:
27542609
31.

Enhancing flora balance in the gastrointestinal tract of mice by lactic acid bacteria from Chinese sourdough and enzyme activities indicative of metabolism of protein, fat, and carbohydrate by the flora.

Yang D, Yu X, Wu Y, Chen X, Wei H, Shah NP, Xu F.

J Dairy Sci. 2016 Oct;99(10):7809-7820. doi: 10.3168/jds.2016-11467. Epub 2016 Jul 21.

PMID:
27448855
32.

Utilization of konjac glucomannan as a fat replacer in low-fat and skimmed yogurt.

Dai S, Corke H, Shah NP.

J Dairy Sci. 2016 Sep;99(9):7063-7074. doi: 10.3168/jds.2016-11131. Epub 2016 Jun 29.

PMID:
27372590
33.

Integration of genomic and proteomic data to identify candidate genes in HT-29 cells after incubation with Bifidobacterium bifidum ATCC 29521.

Wang BG, Wu Y, Qiu L, Shah NP, Xu F, Wei H.

J Dairy Sci. 2016 Sep;99(9):6874-6888. doi: 10.3168/jds.2015-10577. Epub 2016 Jun 29.

PMID:
27372578
34.

Short communication: Modulation of the small intestinal microbial community composition over short-term or long-term administration with Lactobacillus plantarum ZDY2013.

Xie Q, Pan M, Huang R, Tian X, Tao X, Shah NP, Wei H, Wan C.

J Dairy Sci. 2016 Sep;99(9):6913-6921. doi: 10.3168/jds.2016-11141. Epub 2016 Jun 16.

PMID:
27320669
35.

Acute decompensated heart failure as the initial presentation of isolated aortitis.

Lee K, Shah NP, Christenson ES, Zakaria S, Okwuosa I.

Future Cardiol. 2016 Jul;12(4):467-70. doi: 10.2217/fca-2016-0005. Epub 2016 Jun 13.

PMID:
27291815
36.

Antioxidant, Antibacterial, and Antiproliferative Activities of Free and Bound Phenolics from Peel and Flesh of Fuji Apple.

Luo J, Zhang P, Li S, Shah NP.

J Food Sci. 2016 Jul;81(7):M1735-42. doi: 10.1111/1750-3841.13353. Epub 2016 Jun 6.

PMID:
27272442
37.

Cross-cover of oral and maxillofacial surgery out-of-hours: an audit of a new adult treatment clinic.

Abou-Foul AK, Shah NP, Mirza J, Anand P.

Br J Oral Maxillofac Surg. 2016 Oct;54(8):868-871. doi: 10.1016/j.bjoms.2016.05.028. Epub 2016 Jun 5.

PMID:
27266976
38.

Final 5-Year Study Results of DASISION: The Dasatinib Versus Imatinib Study in Treatment-Naïve Chronic Myeloid Leukemia Patients Trial.

Cortes JE, Saglio G, Kantarjian HM, Baccarani M, Mayer J, Boqué C, Shah NP, Chuah C, Casanova L, Bradley-Garelik B, Manos G, Hochhaus A.

J Clin Oncol. 2016 Jul 10;34(20):2333-40. doi: 10.1200/JCO.2015.64.8899. Epub 2016 May 23.

39.

Dasatinib in imatinib-resistant or -intolerant chronic-phase, chronic myeloid leukemia patients: 7-year follow-up of study CA180-034.

Shah NP, Rousselot P, Schiffer C, Rea D, Cortes JE, Milone J, Mohamed H, Healey D, Kantarjian H, Hochhaus A, Saglio G.

Am J Hematol. 2016 Sep;91(9):869-74. doi: 10.1002/ajh.24423. Epub 2016 Jun 20.

40.

Biologics or tofacitinib for rheumatoid arthritis in incomplete responders to methotrexate or other traditional disease-modifying anti-rheumatic drugs: a systematic review and network meta-analysis.

Singh JA, Hossain A, Tanjong Ghogomu E, Kotb A, Christensen R, Mudano AS, Maxwell LJ, Shah NP, Tugwell P, Wells GA.

Cochrane Database Syst Rev. 2016 May 13;(5):CD012183. doi: 10.1002/14651858.CD012183. Review.

PMID:
27175934
41.

The MERTK/FLT3 inhibitor MRX-2843 overcomes resistance-conferring FLT3 mutations in acute myeloid leukemia.

Minson KA, Smith CC, DeRyckere D, Libbrecht C, Lee-Sherick AB, Huey MG, Lasater EA, Kirkpatrick GD, Stashko MA, Zhang W, Jordan CT, Kireev D, Wang X, Frye SV, Earp HS, Shah NP, Graham DK.

JCI Insight. 2016 Mar;1(3):e85630.

42.

Viability, Acid and Bile Tolerance of Spray Dried Probiotic Bacteria and Some Commercial Probiotic Supplement Products Kept at Room Temperature.

Dianawati D, Mishra V, Shah NP.

J Food Sci. 2016 Jun;81(6):M1472-9. doi: 10.1111/1750-3841.13313. Epub 2016 May 3.

PMID:
27145163
43.

Ponatinib versus imatinib for newly diagnosed chronic myeloid leukaemia: an international, randomised, open-label, phase 3 trial.

Lipton JH, Chuah C, Guerci-Bresler A, Rosti G, Simpson D, Assouline S, Etienne G, Nicolini FE, le Coutre P, Clark RE, Stenke L, Andorsky D, Oehler V, Lustgarten S, Rivera VM, Clackson T, Haluska FG, Baccarani M, Cortes JE, Guilhot F, Hochhaus A, Hughes T, Kantarjian HM, Shah NP, Talpaz M, Deininger MW; EPIC investigators.

Lancet Oncol. 2016 May;17(5):612-21. doi: 10.1016/S1470-2045(16)00080-2. Epub 2016 Apr 12.

PMID:
27083332
44.
45.

Lymphocytosis after treatment with dasatinib in chronic myeloid leukemia: Effects on response and toxicity.

Schiffer CA, Cortes JE, Hochhaus A, Saglio G, le Coutre P, Porkka K, Mustjoki S, Mohamed H, Shah NP.

Cancer. 2016 May 1;122(9):1398-407. doi: 10.1002/cncr.29933. Epub 2016 Mar 21.

46.

Screening probiotic strains for safety: Evaluation of virulence and antimicrobial susceptibility of enterococci from healthy Chinese infants.

Zhang F, Jiang M, Wan C, Chen X, Chen X, Tao X, Shah NP, Wei H.

J Dairy Sci. 2016 Jun;99(6):4282-4290. doi: 10.3168/jds.2015-10690. Epub 2016 Mar 16.

PMID:
26995141
47.

High γ-aminobutyric acid production from lactic acid bacteria: Emphasis on Lactobacillus brevis as a functional dairy starter.

Wu Q, Shah NP.

Crit Rev Food Sci Nutr. 2017 Nov 22;57(17):3661-3672. doi: 10.1080/10408398.2016.1147418. Review.

PMID:
26980301
48.
50.

Integrating omics to unravel the stress-response mechanisms in probiotic bacteria: Approaches, challenges, and prospects.

Gandhi A, Shah NP.

Crit Rev Food Sci Nutr. 2017 Nov 2;57(16):3464-3471. doi: 10.1080/10408398.2015.1136805. Review.

PMID:
26853094

Supplemental Content

Support Center